Soligenix Inc (SNGX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.15
• Market Cap: $11.90M
• EPS: $-3.44
• 52-Week High: $6.23
• 52-Week Low: $1.02

Market Sentiment

Soligenix Inc currently has a Bullish sentiment score of 0.45.

About Soligenix Inc

Soligenix Inc. is a clinical-stage biopharmaceutical company based in Princeton, New Jersey, dedicated to the development and commercialization of innovative treatments for rare diseases, particularly in oncology and inflammation. The company boasts a diverse pipeline of therapeutic candidates that address critical unmet medical needs, highlighting its commitment to improving patient outcomes. With a strategic focus on rare diseases, Soligenix is well-positioned in a niche market, presenting ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Soligenix Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SNGX pay dividends?

Soligenix Inc (SNGX) does not currently pay a regular dividend.

What is SNGX's market cap?

Soligenix Inc (SNGX) has a market capitalization of $11.90M with a current stock price of $1.15.